Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Sponsors and Collaborators
Samsung Medical Center
Samsung Biomedical Research Institute

Contact
Kyu-Sung Lee, Ph.D    
82-2-3410-3554    
ksleedr@skku.edu

Principal Investigator
Kyu-Sung Lee, Ph.D, Samsung Medical Center

ClinicalTrials.gov Identifier
NCT01499069

close

Next Article in Overactive Bladder Clinical Trials

More in Overactive Bladder Clinical Trials

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for ...

A look at the following clinical trial: Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug.

Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat ...

A look at the following clinical trial: Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder.

Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease

A look at the following clinical trial: Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease.